Cargando…
Oncogene-mediated metabolic gene signature predicts breast cancer outcome
Breast cancer remains the second most lethal cancer among women in the United States and triple-negative breast cancer is the most aggressive subtype with limited treatment options. Trop2, a cell membrane glycoprotein, is overexpressed in almost all epithelial cancers. In this study, we demonstrate...
Autores principales: | Aslan, Merve, Hsu, En-Chi, Garcia-Marques, Fernando J., Bermudez, Abel, Liu, Shiqin, Shen, Michelle, West, Meredith, Zhang, Chiyuan Amy, Rice, Meghan A., Brooks, James D., West, Robert, Pitteri, Sharon J., Győrffy, Balázs, Stoyanova, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553750/ https://www.ncbi.nlm.nih.gov/pubmed/34711841 http://dx.doi.org/10.1038/s41523-021-00341-6 |
Ejemplares similares
-
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer
por: Liu, Shiqin, et al.
Publicado: (2020) -
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
por: Liu, Shiqin, et al.
Publicado: (2021) -
Quantifying the invasion and migration ability of cancer cells with a 3D Matrigel drop invasion assay
por: Aslan, Merve, et al.
Publicado: (2021) -
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
por: Hsu, En-Chi, et al.
Publicado: (2021) -
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
por: Hsu, En-Chi, et al.
Publicado: (2020)